Monitor the upcoming 10-Q for the fiscal quarter ending September 30, 2026, which will contain the full employment agreements. The transition appears orderly with no red flags.
Price Chart
Executive Summary
Achieve Life Sciences announced the appointment of Benjamin Halladay as CFO, effective October 5, 2026, replacing Mark Oki who stepped down. The departure is not due to any disagreement over financial disclosures, and a replacement was named immediately, making this a routine CFO transition.
Key Facts
- Benjamin Halladay appointed CFO effective October 5, 2026, replacing Mark Oki.
- Halladay previously served as CFO of Esperion Therapeutics from Nov 2022 to Sep 2026.
- Oki's departure is not due to any disagreement regarding financial statements or disclosures.
- Halladay receives $525,000 base salary, up to 40% bonus, 200,000 stock options, and 200,000 RSUs.
- Severance terms include 9 months base salary (or 12 months if tied to change in control) plus accelerated vesting.
Financial Impact
No immediate financial impact; CFO compensation package disclosed but no material change to operations.
Risk Factors
- Potential disruption from CFO transition if Halladay's integration is slower than expected.
- No disclosed financial guidance or operational updates in this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-410781 |
| Document: 0001193125-26-410781-index-headers.html | 0001193125-26-410781 |
| Document: 0001193125-26-410781-index.html | 0001193125-26-410781 |
| Document: 0001193125-26-410781.txt | 0001193125-26-410781 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 3 | $7.24 $7.19 | ▼ −0.69% | ▼ −0.27% | $6.54 (−9.67%) |
Oct 1, 2026 25d ago | 8-K | $7.24 $7.01 | ▼ −3.18% | ▼ −3.85% | $6.54 (−9.67%) |
Aug 14, 2026 10w ago | 8-K | $7.50 $7.52 | ▼ −0.27% | ▼ −0.94% | $6.54 (+12.80%) |
Aug 11, 2026 10w ago | 8-K | $6.69 $7.25 | ▲ +8.37% | ▲ +7.67% | $6.54 (−2.24%) |
Aug 11, 2026 10w ago | Press Release | $6.77 $6.69 | ▲ +1.18% | ▲ +1.43% | $6.54 (+3.40%) |
Aug 7, 2026 11w ago | Institutional Cluster | $6.65 $6.67 | ▲ +0.30% | ▲ +0.33% | $6.54 (−1.65%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.52 $5.52 | · 0.00% | ▲ +0.54% | $6.54 (−18.48%) |
Jun 2, 2026 20w ago | 8-K | $5.03 $4.92 | ▼ −2.19% | ▼ −1.49% | $6.54 (+30.02%) |
May 22, 2026 22w ago | EFFECT | $4.69 $4.56 | ▲ +2.77% | ▲ +3.36% | $6.54 (−39.45%) |
May 19, 2026 22w ago | Press Release | $4.45 $4.57 | ▲ +2.70% | ▲ +1.66% | $6.54 (+46.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers